IL6 and type 2 diabetes mellitus: Since IL-1β and IL-6 levels are increased in type 2 diabetes and are primarily released from adipose tissue and visceral fat, it can be hypothesized that these pro-inflammatory cytokines may support the accumulation of MDSCs in adipose tissue [42,84].